New and TALENted Genome Engineering Toolbox

Recent advances in the burgeoning field of genome engineering are accelerating the realization of personalized therapeutics for cardiovascular disease. In the postgenomic era, sequence-specific gene-editing tools enable the functional analysis of genetic alterations implicated in disease. In partnership with high-throughput model systems, efficient gene manipulation provides an increasingly powerful toolkit to study phenotypes associated with patient-specific genetic defects. Herein, this review emphasizes the latest developments in genome engineering and how applications within the field are transforming our understanding of personalized medicine with an emphasis on cardiovascular diseases.

[1]  Nicholas J. Booher,et al.  Tools for TAL effector design and target prediction. , 2014, Methods.

[2]  J. Keith Joung,et al.  High frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells , 2013, Nature Biotechnology.

[3]  Yoon-Young Jang,et al.  Efficient drug screening and gene correction for treating liver disease using patient‐specific stem cells , 2013, Hepatology.

[4]  S. Ekker,et al.  High Efficiency In Vivo Genome Engineering with a Simplified 15-RVD GoldyTALEN Design , 2013, PloS one.

[5]  Hui Zhao,et al.  Generation of gene disruptions by transcription activator-like effector nucleases (TALENs) in Xenopus tropicalis embryos , 2013, Cell & Bioscience.

[6]  Ryan M. O’Connell,et al.  Targeting Human MicroRNA Genes Using Engineered Tal-Effector Nucleases (TALENs) , 2013, PloS one.

[7]  Xia Li,et al.  High-efficiency and heritable gene targeting in mouse by transcription activator-like effector nucleases , 2013, Nucleic acids research.

[8]  S. Ekker,et al.  The CRISPR system--keeping zebrafish gene targeting fresh. , 2013, Zebrafish.

[9]  M. Tomishima,et al.  Cancer translocations in human cells induced by zinc finger and TALE nucleases , 2013, Genome research.

[10]  Tetsushi Sakuma,et al.  Efficient TALEN construction and evaluation methods for human cell and animal applications , 2013, Genes to cells : devoted to molecular & cellular mechanisms.

[11]  S. Bhattacharya,et al.  Site Specific Mutation of the Zic2 Locus by Microinjection of TALEN mRNA in Mouse CD1, C3H and C57BL/6J Oocytes , 2013, PloS one.

[12]  Xiaojun Zhu,et al.  Genome editing with RNA-guided Cas9 nuclease in Zebrafish embryos , 2013, Cell Research.

[13]  Michelle A. E. Anderson,et al.  TALEN-Based Gene Disruption in the Dengue Vector Aedes aegypti , 2013, PloS one.

[14]  Karl-Ludwig Laugwitz,et al.  Induced Pluripotent Stem Cell-Derived Cardiomyocytes: A Versatile Tool for Arrhythmia Research , 2013, Circulation research.

[15]  Xiaoming Sheng,et al.  An In Vivo Cardiac Assay to Determine the Functional Consequences of Putative Long QT Syndrome Mutations , 2013, Circulation research.

[16]  Shuo Lin,et al.  TALEN-mediated precise genome modification by homologous recombination in zebrafish , 2013, Nature Methods.

[17]  Wolfgang Wurst,et al.  Direct production of mouse disease models by embryo microinjection of TALENs and oligodeoxynucleotides , 2013, Proceedings of the National Academy of Sciences.

[18]  Duhee Bang,et al.  A library of TAL effector nucleases spanning the human genome , 2013, Nature Biotechnology.

[19]  S. Chandrasegaran,et al.  Generation and genetic engineering of human induced pluripotent stem cells using designed zinc finger nucleases. , 2013, Stem cells and development.

[20]  James E. DiCarlo,et al.  RNA-Guided Human Genome Engineering via Cas9 , 2013, Science.

[21]  M. Tomita,et al.  Quantitative assay for TALEN activity at endogenous genomic loci , 2013, Biology Open.

[22]  O. Yanuka,et al.  Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a high-throughput screen. , 2013, Cell stem cell.

[23]  Kevin Kim,et al.  A TALEN genome-editing system for generating human stem cell-based disease models. , 2013, Cell stem cell.

[24]  P. Bradley,et al.  TAL effectors: function, structure, engineering and applications. , 2013, Current opinion in structural biology.

[25]  Stephen C. Ekker,et al.  Mojo Hand, a TALEN design tool for genome editing applications , 2013, BMC Bioinformatics.

[26]  Biao Lu,et al.  A do-it-yourself protocol for simple transcription activator-like effector assembly , 2013, Biological Procedures Online.

[27]  Steven A. Harvey,et al.  A systematic genome-wide analysis of zebrafish protein-coding gene function , 2013, Nature.

[28]  Igor Antoshechkin,et al.  A large-scale in vivo analysis reveals that TALENs are significantly more mutagenic than ZFNs generated using context-dependent assembly , 2013, Nucleic acids research.

[29]  Carlo Napolitano,et al.  Induced pluripotent stem cell-derived cardiomyocytes in studies of inherited arrhythmias. , 2013, The Journal of clinical investigation.

[30]  Han-Woong Lee,et al.  Knockout mice created by TALEN-mediated gene targeting , 2013, Nature Biotechnology.

[31]  T. Cathomen,et al.  Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells , 2012, Nucleic acids research.

[32]  Tobias Schmidt,et al.  A ligation-independent cloning technique for high-throughput assembly of transcription activator–like effector genes , 2012, Nature Biotechnology.

[33]  S. Hsiao,et al.  Enrichment of neonatal rat cardiomyocytes in primary culture facilitates long-term maintenance of contractility in vitro. , 2012, American journal of physiology. Cell physiology.

[34]  Frank Soldner,et al.  iPSC Disease Modeling , 2012, Science.

[35]  J. Keith Joung,et al.  TALENs: a widely applicable technology for targeted genome editing , 2012, Nature Reviews Molecular Cell Biology.

[36]  Xiaolei Xu,et al.  Anemic Zebrafish Models of Cardiomyopathy , 2012 .

[37]  E. Bouhassira,et al.  Zinc-finger nuclease-mediated correction of α-thalassemia in iPS cells. , 2012, Blood.

[38]  M. Andreassi,et al.  Next generation sequencing in cardiovascular diseases. , 2012, World journal of cardiology.

[39]  I. Dawid,et al.  Efficient targeted gene disruption in Xenopus embryos using engineered transcription activator-like effector nucleases (TALENs) , 2012, Proceedings of the National Academy of Sciences.

[40]  Timothy J. Nelson,et al.  Apoptotic Susceptibility to DNA Damage of Pluripotent Stem Cells Facilitates Pharmacologic Purging of Teratoma Risk , 2012, Stem cells translational medicine.

[41]  Jeffry D. Sander,et al.  Engineering Designer Transcription Activator‐‐Like Effector Nucleases (TALENs) by REAL or REAL‐Fast Assembly , 2012, Current protocols in molecular biology.

[42]  Xiaolei Xu,et al.  α‐Actinin2 is required for the lateral alignment of Z discs and ventricular chamber enlargement during zebrafish cardiogenesis , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  Daniel F. Voytas,et al.  Efficient TALEN-mediated gene knockout in livestock , 2012, Proceedings of the National Academy of Sciences.

[44]  Fayza Daboussi,et al.  Overcoming Transcription Activator-like Effector (TALE) DNA Binding Domain Sensitivity to Cytosine Methylation*♦ , 2012, The Journal of Biological Chemistry.

[45]  Daniel F. Voytas,et al.  Targeting G with TAL Effectors: A Comparison of Activities of TALENs Constructed with NN and NK Repeat Variable Di-Residues , 2012, PloS one.

[46]  Shuo Lin,et al.  Reverse genetic approaches in zebrafish. , 2012, Journal of genetics and genomics = Yi chuan xue bao.

[47]  Ying Lin,et al.  Highly Efficient and Specific Genome Editing in Silkworm Using Custom TALENs , 2012, PloS one.

[48]  Xinqi Gong,et al.  Recognition of methylated DNA by TAL effectors , 2012, Cell Research.

[49]  Shinsuke Yuasa,et al.  Disease characterization using LQTS-specific induced pluripotent stem cells. , 2012, Cardiovascular research.

[50]  Barry J Maron,et al.  Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives. , 2012, Journal of the American College of Cardiology.

[51]  J. Doudna,et al.  A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity , 2012, Science.

[52]  Daniel F. Voytas,et al.  Simple Methods for Generating and Detecting Locus-Specific Mutations Induced with TALENs in the Zebrafish Genome , 2012, PLoS genetics.

[53]  Jens Boch,et al.  TAL effector RVD specificities and efficiencies , 2012, Nature Biotechnology.

[54]  C. Mummery,et al.  Cardiomyocytes Derived From Pluripotent Stem Cells Recapitulate Electrophysiological Characteristics of an Overlap Syndrome of Cardiac Sodium Channel Disease , 2012, Circulation.

[55]  George M. Church,et al.  Iterative capped assembly: rapid and scalable synthesis of repeat-module DNA such as TAL effectors from individual monomers , 2012, Nucleic acids research.

[56]  Volker Brendel,et al.  TAL Effector-Nucleotide Targeter (TALE-NT) 2.0: tools for TAL effector design and target prediction , 2012, Nucleic Acids Res..

[57]  J. Keith Joung,et al.  Highly efficient generation of heritable zebrafish gene mutations using homo- and heterodimeric TALENs , 2012, Nucleic acids research.

[58]  T. Tada,et al.  Genome editing in induced pluripotent stem cells , 2012, Genes to cells : devoted to molecular & cellular mechanisms.

[59]  J. Keith Joung,et al.  Improved Somatic Mutagenesis in Zebrafish Using Transcription Activator-Like Effector Nucleases (TALENs) , 2012, PloS one.

[60]  R. Jiao,et al.  Efficient and specific modifications of the Drosophila genome by means of an easy TALEN strategy. , 2012, Journal of genetics and genomics = Yi chuan xue bao.

[61]  A. Jaźwińska,et al.  Induction of Myocardial Infarction in Adult Zebrafish Using Cryoinjury , 2012, Journal of visualized experiments : JoVE.

[62]  Euan A. Ashley,et al.  Patient-Specific Induced Pluripotent Stem Cells as a Model for Familial Dilated Cardiomyopathy , 2012, Science Translational Medicine.

[63]  Huimin Zhao,et al.  Optimized TAL effector nucleases (TALENs) for use in treatment of sickle cell disease. , 2012, Molecular bioSystems.

[64]  N. Mercader,et al.  Cryoinjury as a myocardial infarction model for the study of cardiac regeneration in the zebrafish , 2012, Nature Protocols.

[65]  Y. Furutani,et al.  Prospective In Vitro Models of Channelopathies and Cardiomyopathies , 2012, Stem cells international.

[66]  H. Leonhardt,et al.  Targeted transcriptional activation of silent oct4 pluripotency gene by combining designer TALEs and inhibition of epigenetic modifiers , 2012, Nucleic acids research.

[67]  Laura Iop,et al.  Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia , 2012, EMBO molecular medicine.

[68]  Chetana Sachidanandan,et al.  In vivo natriuretic peptide reporter assay identifies chemical modifiers of hypertrophic cardiomyopathy signalling. , 2012, Cardiovascular research.

[69]  Ofer Binah,et al.  Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to β-adrenergic stimulation , 2012, Journal of cellular and molecular medicine.

[70]  Philip Bradley,et al.  The Crystal Structure of TAL Effector PthXo1 Bound to Its DNA Target , 2012, Science.

[71]  Ke Chen,et al.  Genetic correction of β-thalassemia patient-specific iPS cells and its use in improving hemoglobin production in irradiated SCID mice , 2012, Cell Research.

[72]  Jianyong Xu,et al.  Generation of CD34+ cells from CCR5-disrupted human embryonic and induced pluripotent stem cells. , 2012, Human gene therapy.

[73]  Ruhong Zhou,et al.  Comprehensive Interrogation of Natural TALE DNA Binding Modules and Transcriptional Repressor Domains , 2012, Nature Communications.

[74]  Takahito Watanabe,et al.  Non-transgenic genome modifications in a hemimetabolous insect using zinc-finger and TAL effector nucleases , 2012, Nature Communications.

[75]  Neville E Sanjana,et al.  A transcription activator-like effector toolbox for genome engineering , 2012, Nature Protocols.

[76]  Azra Fatima,et al.  In vitro Modeling of Ryanodine Receptor 2 Dysfunction Using Human Induced Pluripotent Stem Cells , 2011, Cellular Physiology and Biochemistry.

[77]  J. Witztum,et al.  In vivo visualization and attenuation of oxidized lipid accumulation in hypercholesterolemic zebrafish. , 2011, The Journal of clinical investigation.

[78]  Andrew P. Feinberg,et al.  Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells , 2011, Nature Biotechnology.

[79]  Katriina Aalto-Setälä,et al.  Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture , 2011, Disease Models & Mechanisms.

[80]  Morgan L. Maeder,et al.  In Situ Genetic Correction of the Sickle Cell Anemia Mutation in Human Induced Pluripotent Stem Cells Using Engineered Zinc Finger Nucleases , 2011, Stem cells.

[81]  P. Mali,et al.  Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease. , 2011, Blood.

[82]  A. Bogdanove,et al.  TAL Effectors: Customizable Proteins for DNA Targeting , 2011, Science.

[83]  S. Sivasubbu,et al.  Haploinsufficiency of Target of Rapamycin Attenuates Cardiomyopathies in Adult Zebrafish , 2011, Circulation research.

[84]  D. Sahoo,et al.  An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells , 2011, Nature Biotechnology.

[85]  Shondra M Pruett-Miller,et al.  High-frequency genome editing using ssDNA oligonucleotides with zinc-finger nucleases , 2011, Nature Methods.

[86]  Li Wang,et al.  Erratum: Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting (Nucleic Acids Research (2011) 39 (e82) DOI: 10.1093/nar/gkr218) , 2011 .

[87]  A. Bradley,et al.  Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells , 2011, Nature.

[88]  Claudio Mussolino,et al.  A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity , 2011, Nucleic acids research.

[89]  An Xiao,et al.  Heritable gene targeting in zebrafish using customized TALENs , 2011, Nature Biotechnology.

[90]  Elo Leung,et al.  Knockout rats generated by embryo microinjection of TALENs , 2011, Nature Biotechnology.

[91]  J. Keith Joung,et al.  Targeted gene disruption in somatic zebrafish cells using engineered TALENs , 2011, Nature Biotechnology.

[92]  S. Wolfe,et al.  Forward and reverse genetic approaches for the analysis of vertebrate development in the zebrafish. , 2011, Developmental cell.

[93]  Elo Leung,et al.  Targeted Genome Editing Across Species Using ZFNs and TALENs , 2011, Science.

[94]  Susan Lindquist,et al.  Generation of Isogenic Pluripotent Stem Cells Differing Exclusively at Two Early Onset Parkinson Point Mutations , 2011, Cell.

[95]  Jeroen Bakkers,et al.  Zebrafish as a model to study cardiac development and human cardiac disease , 2011, Cardiovascular research.

[96]  N. Mercader,et al.  Extensive scar formation and regression during heart regeneration after cryoinjury in zebrafish , 2011, Development.

[97]  K. Narsinh,et al.  Derivation of Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling , 2011, Circulation research.

[98]  Erin L. Doyle,et al.  Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting , 2011, Nucleic acids research.

[99]  T. Kurth,et al.  Regeneration of Cryoinjury Induced Necrotic Heart Lesions in Zebrafish Is Associated with Epicardial Activation and Cardiomyocyte Proliferation , 2011, PloS one.

[100]  G. Rainer,et al.  The zebrafish heart regenerates after cryoinjury-induced myocardial infarction , 2011, BMC Developmental Biology.

[101]  Susan Carpenter,et al.  Modularly assembled designer TAL effector nucleases for targeted gene knockout and gene replacement in eukaryotes , 2011, Nucleic acids research.

[102]  Lior Gepstein,et al.  Modelling the long QT syndrome with induced pluripotent stem cells , 2011, Nature.

[103]  Jonathan A. Bernstein,et al.  Using iPS cells to investigate cardiac phenotypes in patients with Timothy Syndrome , 2011, Nature.

[104]  Divya Rajamohan,et al.  Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation , 2011, European heart journal.

[105]  H. Riele,et al.  Progress and prospects: oligonucleotide-directed gene modification in mouse embryonic stem cells: a route to therapeutic application , 2011, Gene Therapy.

[106]  Elo Leung,et al.  A TALE nuclease architecture for efficient genome editing , 2011, Nature Biotechnology.

[107]  Jens Boch,et al.  TAL effectors are remote controls for gene activation. , 2011, Current opinion in microbiology.

[108]  Timothy J. Nelson,et al.  Nuclear Reprogramming Strategy Modulates Differentiation Potential of Induced Pluripotent Stem Cells , 2011, Journal of cardiovascular translational research.

[109]  Robert W. Mills,et al.  Novel Chemical Suppressors of Long QT Syndrome Identified by an In Vivo Functional Screen , 2011, Circulation.

[110]  S. Yamanaka,et al.  Cell line-dependent differentiation of induced pluripotent stem cells into cardiomyocytes in mice. , 2010, Cardiovascular research.

[111]  Monte Westerfield,et al.  ZFIN: enhancements and updates to the zebrafish model organism database , 2010, Nucleic Acids Res..

[112]  Karl-Ludwig Laugwitz,et al.  Patient-specific induced pluripotent stem-cell models for long-QT syndrome. , 2010, New England Journal of Medicine.

[113]  Erin L. Doyle,et al.  Targeting DNA Double-Strand Breaks with TAL Effector Nucleases , 2010, Genetics.

[114]  Sheng Huang,et al.  TAL nucleases (TALNs): hybrid proteins composed of TAL effectors and FokI DNA-cleavage domain , 2010, Nucleic Acids Res..

[115]  A. Bogdanove,et al.  TAL effectors: finding plant genes for disease and defense. , 2010, Current opinion in plant biology.

[116]  S. Yamanaka,et al.  Recent Stem Cell Advances: Induced Pluripotent Stem Cells for Disease Modeling and Stem Cell–Based Regeneration , 2010, Circulation.

[117]  Thomas Gaj,et al.  Directed evolution of an enhanced and highly efficient FokI cleavage domain for zinc finger nucleases. , 2010, Journal of molecular biology.

[118]  Martin J. Aryee,et al.  Epigenetic memory in induced pluripotent stem cells , 2010, Nature.

[119]  Drena Dobbs,et al.  ZiFiT (Zinc Finger Targeter): an updated zinc finger engineering tool , 2010, Nucleic Acids Res..

[120]  K. Schwarz,et al.  Zinc-finger nuclease-induced gene repair with oligodeoxynucleotides: wanted and unwanted target locus modifications. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[121]  Lei Yang,et al.  Patient-specific induced pluripotent stem cell derived models of LEOPARD syndrome , 2010, Nature.

[122]  Timothy J. Nelson,et al.  c-MYC-Independent Nuclear Reprogramming Favors Cardiogenic Potential of Induced Pluripotent Stem Cells , 2010, Journal of cardiovascular translational research.

[123]  W. Rottbauer,et al.  In-vivo characterization of human dilated cardiomyopathy genes in zebrafish. , 2009, Biochemical and biophysical research communications.

[124]  Jens Boch,et al.  Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors , 2009, Science.

[125]  Matthew J. Moscou,et al.  A Simple Cipher Governs DNA Recognition by TAL Effectors , 2009, Science.

[126]  W. Rottbauer,et al.  Nexilin mutations destabilize cardiac Z-disks and lead to dilated cardiomyopathy , 2009, Nature Medicine.

[127]  R. Jaenisch,et al.  Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases , 2009, Nature Biotechnology.

[128]  B. Paw,et al.  Cardiac Hypertrophy Involves Both Myocyte Hypertrophy and Hyperplasia in Anemic Zebrafish , 2009, PloS one.

[129]  Soo-Ho Choi,et al.  Vascular Lipid Accumulation, Lipoprotein Oxidation, and Macrophage Lipid Uptake in Hypercholesterolemic Zebrafish , 2009, Circulation research.

[130]  Carola Engler,et al.  A One Pot, One Step, Precision Cloning Method with High Throughput Capability , 2008, PloS one.

[131]  A. Seluanov,et al.  Comparison of nonhomologous end joining and homologous recombination in human cells. , 2008, DNA repair.

[132]  Calum A Macrae,et al.  Zebrafish genetic models for arrhythmia. , 2008, Progress in biophysics and molecular biology.

[133]  W. Rottbauer,et al.  Depletion of zebrafish essential and regulatory myosin light chains reduces cardiac function through distinct mechanisms. , 2008, Cardiovascular research.

[134]  M. Noyes,et al.  Targeted gene inactivation in zebrafish using engineered zinc-finger nucleases , 2008, Nature Biotechnology.

[135]  Yun Deng,et al.  A web based resource characterizing the zebrafish developmental profile of over 16,000 transcripts. , 2008, Gene expression patterns : GEP.

[136]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[137]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[138]  T. Graf.  Faculty Opinions recommendation of Induction of pluripotent stem cells from adult human fibroblasts by defined factors. , 2007 .

[139]  N. Schork,et al.  Laminin-&agr;4 and Integrin-Linked Kinase Mutations Cause Human Cardiomyopathy Via Simultaneous Defects in Cardiomyocytes and Endothelial Cells , 2007 .

[140]  Jan Huisken,et al.  Zebrafish model for human long QT syndrome , 2007, Proceedings of the National Academy of Sciences.

[141]  Adam James Waite,et al.  An improved zinc-finger nuclease architecture for highly specific genome editing , 2007, Nature Biotechnology.

[142]  D. Hydock,et al.  Doxorubicin cardiotoxicity in the rat: an in vivo characterization. , 2007, Journal of the American Association for Laboratory Animal Science : JAALAS.

[143]  P. Burridge,et al.  Improved Human Embryonic Stem Cell Embryoid Body Homogeneity and Cardiomyocyte Differentiation from a Novel V‐96 Plate Aggregation System Highlights Interline Variability , 2007, Stem cells.

[144]  C. Bagowski,et al.  Zebrafish cypher is important for somite formation and heart development. , 2006, Developmental biology.

[145]  R. Autschbach,et al.  Doxorubicin in experimental and clinical heart failure. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[146]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[147]  Sebastian Schornack,et al.  Gene-for-gene-mediated recognition of nuclear-targeted AvrBs3-like bacterial effector proteins. , 2006, Journal of plant physiology.

[148]  P. Doevendans,et al.  The human adult cardiomyocyte phenotype. , 2003, Cardiovascular research.

[149]  D. Hoover,et al.  DNAWorks: an automated method for designing oligonucleotides for PCR-based gene synthesis. , 2002, Nucleic acids research.

[150]  Didier Y. R. Stainier,et al.  Cardiac troponin T is essential in sarcomere assembly and cardiac contractility , 2002, Nature Genetics.

[151]  Mark C. Fishman,et al.  Cardiomyopathy in zebrafish due to mutation in an alternatively spliced exon of titin , 2002, Nature Genetics.

[152]  D. Valle,et al.  Online Mendelian Inheritance In Man (OMIM) , 2000, Human mutation.

[153]  A. Schier,et al.  Mutations affecting the formation and function of the cardiovascular system in the zebrafish embryo. , 1996, Development.

[154]  S Chandrasegaran,et al.  Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[155]  J. Rashbass.  Online Mendelian Inheritance in Man. , 1995, Trends in genetics : TIG.

[156]  D. F. Carlson,et al.  328 VERSATILE TRANSCRIPTION ACTIVATOR-LIKE EFFECTOR NUCLEASE (TALEN)-MEDIATED ENGINEERING OF OSSABAW MINIATURE SWINE , 2013 .

[157]  Mark D. Huffman,et al.  Heart disease and stroke statistics--2013 update: a report from the American Heart Association. , 2013, Circulation.

[158]  T. Bíró,et al.  TRP Channels in Drug Discovery , 2012, Methods in Pharmacology and Toxicology.

[159]  Thuy D Vo,et al.  Enhancing zinc-finger-nuclease activity with improved obligate heterodimeric architectures , 2011, Nature Methods.

[160]  W. Rottbauer,et al.  Fishing for the genetic basis of cardiovascular disease , 2009, Disease Models & Mechanisms.

[161]  A. Kimura.  Molecular etiology and pathogenesis of hereditary cardiomyopathy. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[162]  N. Schork,et al.  Laminin-alpha4 and integrin-linked kinase mutations cause human cardiomyopathy via simultaneous defects in cardiomyocytes and endothelial cells. , 2007, Circulation.

[163]  B. Thisse,et al.  High-resolution in situ hybridization to whole-mount zebrafish embryos , 2007, Nature Protocols.

[164]  H. Heffner,et al.  Hearing ranges of laboratory animals. , 2007, Journal of the American Association for Laboratory Animal Science : JAALAS.

[165]  Jeffry D Sander,et al.  FLAsH assembly of TALeNs for high-throughput genome editing , 2022 .